Enveric Biosciences, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Enveric Biosciences, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2025.
  • Enveric Biosciences, Inc. Current Ratio for the quarter ending June 30, 2025 was 312 %, a 28.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 312 +69.3 +28.5% Jun 30, 2025
Q1 2025 419 +227 +118% Mar 31, 2025
Q4 2024 390 +181 +86.8% Dec 31, 2024
Q3 2024 350 +76.1 +27.8% Sep 30, 2024
Q2 2024 243 -161 -39.9% Jun 30, 2024
Q1 2024 192 -369 -65.8% Mar 31, 2024
Q4 2023 209 -543 -72.2% Dec 31, 2023
Q3 2023 274 -568 -67.5% Sep 30, 2023
Q2 2023 404 -477 -54.1% Jun 30, 2023
Q1 2023 561 -471 -45.6% Mar 31, 2023
Q4 2022 751 -518 -40.8% Dec 31, 2022
Q3 2022 841 -657 -43.9% Sep 30, 2022
Q2 2022 881 +525 +148% Jun 30, 2022
Q1 2022 1.03K +863 +512% Mar 31, 2022
Q4 2021 1.27K +1.19K +1551% Dec 31, 2021
Q3 2021 1.5K +1.44K +2583% Sep 30, 2021
Q2 2021 355 +305 +599% Jun 30, 2021
Q1 2021 168 +117 +228% Mar 31, 2021
Q4 2020 76.9 +21.3 +38.4% Dec 31, 2020
Q3 2020 55.8 -15.9 -22.2% Sep 30, 2020
Q2 2020 50.8 -26.4 -34.2% Jun 30, 2020
Q1 2020 51.4 -10.6 -17.1% Mar 31, 2020
Q4 2019 55.5 +3.15 +6.01% Dec 31, 2019
Q3 2019 71.7 +23.2 +47.7% Sep 30, 2019
Q2 2019 77.2 +35.9 +87% Jun 30, 2019
Q1 2019 62 +15.8 +34.2% Mar 31, 2019
Q4 2018 52.4 +0.49 +0.94% Dec 31, 2018
Q3 2018 48.6 -9.29 -16.1% Sep 30, 2018
Q2 2018 41.3 -33.8 -45% Jun 30, 2018
Q1 2018 46.2 -36.3 -44% Mar 31, 2018
Q4 2017 51.9 -33.2 -39% Dec 31, 2017
Q3 2017 57.9 -28.9 -33.3% Sep 30, 2017
Q2 2017 75.1 -17.3 -18.7% Jun 30, 2017
Q1 2017 82.5 -7.87 -8.71% Mar 31, 2017
Q4 2016 85.1 -12.4 -12.7% Dec 31, 2016
Q3 2016 86.8 -15 -14.7% Sep 30, 2016
Q2 2016 92.3 -58.4 -38.8% Jun 30, 2016
Q1 2016 90.3 -142 -61.1% Mar 31, 2016
Q4 2015 97.5 -139 Dec 31, 2015
Q3 2015 102 -134 -56.8% Sep 30, 2015
Q2 2015 151 +38.5 Jun 30, 2015
Q1 2015 232 -91.8 -28.3% Mar 31, 2015
Q4 2014 236* -4.96K Dec 31, 2014
Q3 2014 235 -4.92K Sep 30, 2014
Q2 2014 112* -6.18K Jun 30, 2014
Q1 2014 324 +295 Mar 31, 2014
Q4 2013 5.19K* +5.15K Dec 31, 2013
Q3 2013 5.16K* +5.07K Sep 30, 2013
Q2 2013 6.29K +6.15K Jun 30, 2013
Q1 2013 29.5* -26.4 Mar 31, 2013
Q4 2012 47.6* Dec 31, 2012
Q3 2012 86.8* Sep 30, 2012
Q2 2012 140* Jun 30, 2012
Q1 2012 55.9* Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.